Generic name: tesamorelin
Dosage form: injection
This dosage information does not include all the information needed to use Egrifta safely and effectively. See full prescribing information for Egrifta.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
2.1 Dosing Information
The recommended dose of EGRIFTA® is 2 mg injected subcutaneously once a day.
The recommended injection site is the abdomen. Injection sites should be rotated to different areas of the abdomen. Do not inject into scar tissue, bruises or the navel.
2.2 Reconstitution Instructions
Instructions for reconstituting EGRIFTA® are provided in the INSTRUCTIONS FOR USE leaflet enclosed in the EGRIFTA® medication box and in the injection box.
If not used immediately, the reconstituted EGRIFTA® solution should be discarded. Do not freeze or refrigerate the reconstituted EGRIFTA® solution.
Reconstituted EGRIFTA® solution should always be inspected visually for particulate matter and discoloration prior to administration. EGRIFTA® must be injected only if the solution is clear, colorless and without particulate matter.